Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic continues to spread with devastating consequences. For passive immunization efforts, nanobodies have size and cost advantages over conventional antibodies. Here, we generated four neutralizing nanobodies that target the receptor-binding domain of the SARS-CoV-2 spike protein. We defined two distinct binding epitopes using x-ray crystallography and cryo-electron microscopy. Based on the structures, we engineered multivalent...
United States Baden Wuberg Nordrhein Westfalen Karolinska Institutet Myone Streptavidin Stephan Poehlmann
Source: sciencemag.org